"Extracellular chromatin burden predicts restenosis and survival after transcatheter aortic valve replacement (TAVI)"

Projekt: Forschung

Status	Abgeschlossen
Tatsächlicher Beginn/ -es Ende	23/05/20 → 23/05/21

Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.
Mangold, A., Ondracek, A. S., Hofbauer, T. M., Artner, T., Nechvile, J., Panagiotides, N. G., Mirna, M. (Co-Autor/-in), Hammerer, M. (Co-Autor/-in), Fejzic, D. (Co-Autor/-in), Hoppe, U. (Co-Autor/-in), Wernly, B. (Co-Autor/-in), Lauten, A., Alushi, B., Franz, M., Schulze, P. C., Wohlschläger-Krenn, E., Lang, I. M. & Lichtenauer, M. (Letztautor/-in), 2021, in: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION . 51, 11, S. e13595
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

1 Quellenangabe (Web of Science)

Projektdetails